JPH10279468A5 - - Google Patents

Info

Publication number
JPH10279468A5
JPH10279468A5 JP1997099668A JP9966897A JPH10279468A5 JP H10279468 A5 JPH10279468 A5 JP H10279468A5 JP 1997099668 A JP1997099668 A JP 1997099668A JP 9966897 A JP9966897 A JP 9966897A JP H10279468 A5 JPH10279468 A5 JP H10279468A5
Authority
JP
Japan
Prior art keywords
extract
lignan
lignan glycoside
acid
glycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997099668A
Other languages
Japanese (ja)
Other versions
JPH10279468A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP9099668A priority Critical patent/JPH10279468A/en
Priority claimed from JP9099668A external-priority patent/JPH10279468A/en
Publication of JPH10279468A publication Critical patent/JPH10279468A/en
Publication of JPH10279468A5 publication Critical patent/JPH10279468A5/ja
Pending legal-status Critical Current

Links

Description

【0005】
すなわち、本発明は、次の成分(A)及び(B)
(A)リグナン配糖体
(B)抗炎症剤から選ばれる1種又は2種以上
を含有することを特徴とする皮膚外用剤を提供するものである。本発明の好ましい実施態様としては、以下の特徴を有する。
(1)該リグナン配糖体が、下記の構造式(I)で示されるリグナン配糖体である。
【化5】
(2)該リグナン配糖体が、下記の構造式(II−a)、(II−b)もしくは(II−c)で示されるリグナン配糖体の1種または2種以上を主成分とするリグナン配糖体である。
【化6】
【化7】
【化8】
(3)該リグナン配糖体が、ゴマ種子やその加湿物もしくは発芽体、またはそれらの粉砕物、またはそれらの脱脂物の含水低級アルコール抽出物である。
(4)該抗炎症剤が、グリチルリチン酸、グリチルレチン酸、メフェナム酸、フェニルブタゾン、インドメタシン、イブプロフェン、ケトプロフェン、アラントイン、グアイアズレン、D−パンテノール及びそれらの誘導体並びにそれらの塩、ε−アミノカプロン酸、酸化亜鉛、ジクロフェナクナトリウム、アロエ抽出物、シコン抽出物、サルビア抽出物、ソウハクヒ抽出物、シソ抽出物、カワラヨモギ抽出物、オランダカラシ抽出物、ガマ抽出物、セイヨウニワトコ抽出物、ヒレハリソウ抽出物、アルニカ抽出物、オウバク抽出物、カミツレ抽出物、シラカバ抽出物、オトギリソウ抽出物、ユーカリ抽出物及びムクロジ抽出物から選ばれる1種または2種以上である。
[0005]
That is, the present invention provides a composition comprising the following components (A) and (B):
(A) Lignan glycosides
(B) one or more anti-inflammatory agents
The present invention provides an external skin preparation characterized by comprising the following:
(1) The lignan glycoside is a lignan glycoside represented by the following structural formula (I):
[C5]
(2) The lignan glycoside is a lignan glycoside having as its main component one or more of the lignan glycosides represented by the following structural formula (II-a), (II-b) or (II-c):
[C6]
[Chemical 7]
[Chemical formula 8]
(3) The lignan glycoside is a hydrous lower alcohol extract of sesame seeds, their moistened or germinated products, or their pulverized products, or their defatted products.
(4) The anti-inflammatory agent is one or more selected from glycyrrhizinic acid, glycyrrhetinic acid, mefenamic acid, phenylbutazone, indomethacin, ibuprofen, ketoprofen, allantoin, guaiazulene, D-panthenol and derivatives thereof and salts thereof, ε-aminocaproic acid, zinc oxide, diclofenac sodium, aloe extract, lithospermum root extract, salvia extract, mulberry bark extract, perilla extract, artemisia capillaris extract, watercress extract, cattail extract, elder extract, comfrey extract, arnica extract, phellodendron bark extract, chamomile extract, white birch extract, St. John's wort extract, eucalyptus extract, and soapberry extract.

JP9099668A 1997-04-01 1997-04-01 Skin preparation for external use Pending JPH10279468A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9099668A JPH10279468A (en) 1997-04-01 1997-04-01 Skin preparation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9099668A JPH10279468A (en) 1997-04-01 1997-04-01 Skin preparation for external use

Publications (2)

Publication Number Publication Date
JPH10279468A JPH10279468A (en) 1998-10-20
JPH10279468A5 true JPH10279468A5 (en) 2005-03-03

Family

ID=14253421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9099668A Pending JPH10279468A (en) 1997-04-01 1997-04-01 Skin preparation for external use

Country Status (1)

Country Link
JP (1) JPH10279468A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000136122A (en) * 1998-10-28 2000-05-16 Kose Corp Skin lotion
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
JP5789426B2 (en) * 2011-06-17 2015-10-07 エスエス製薬株式会社 Epidermis turnover accelerator
JP2013155141A (en) * 2012-01-31 2013-08-15 Mikimoto Pharmaceut Co Ltd Cosmetic
CN113164604A (en) * 2018-11-02 2021-07-23 株式会社资生堂 Inhibitors of ultraviolet-induced inflammation comprising alternative autophagy inducers
CN115212157B (en) * 2022-07-14 2023-07-28 百世美生物技术(浙江)有限公司 Preparation method and application of natural plant extract compound herbal raw material for whitening, removing freckles and resisting aging

Similar Documents

Publication Publication Date Title
Schuster et al. Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenes
DE69502147T2 (en) L-carnitine salt and compositions containing it
IL140986A0 (en) Preparation of aqueous clear solution dosage forms with bile acids
KR890015782A (en) Use of calcined hydrotalcite as an ethoxylated or propoxylated catalyst
TNSN04112A1 (en) FORMS OF E-2-METHOXY-N- (3-4- (3-METHYL-PYRIDIN-3-YLOXY) -PHENYLAMINO) -QUINAZOLIN-6-YL) -ALLYL) -ACETAMIDE SALTS, THEIR PREPARATION AND THEIR USE THE CANCER
AU1266900A (en) Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumors
CA2452326A1 (en) Topical leave-on compositions containing selected pantothenic acid derivatives
KR950008635A (en) Process for preparing quinacridone solid solution pigment
TR200003688T1 (en) Composition to increase the absorption of Glutation and strengthen its effects
JPH10279464A5 (en)
WO1989010121A1 (en) N-alkoxyalkylamides and cosmetic treating compositions therewith
CA2333680A1 (en) Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
HU205131B (en) Process for producing dexylosyl derivatives of antibiotics of group bu-3608, as well as pharmaceutical compositions comprising such compounds
JP2004501934A5 (en)
TR200101083T2 (en) High purity composition containing (7alfa, 17alfa) -17-hydroxy- 7-methyl-19-nor-17-pregn-5 (10) -en-20-in-3-one.
JPH01180822A (en) Anti-delayed type allergic agent
JPH11255632A (en) Cosmetic composition
GB977214A (en) Chemical compounds
CN111471067A (en) Methacrylate modified organosilicon quaternary ammonium salt and preparation method and application thereof
Beadle et al. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure–activity studies in human cytomegalovirus-, herpes simplex virus type 1-and human immunodeficiency virus type 1-infected cells
JP2014058619A (en) Carboxymethyl chitosan acetate compound, method for producing the same and cosmetic
KR950701314A (en) Synthesis of Cosmetic Ingredient
US4701444A (en) Topical pharmaceutical preparations containing chitin soluble extract
FR2421173A1 (en) 2- (4-ETHYLPIPERAZINO) -4-PHENYLQUINOLEINE AND ITS SALTS, USEFUL IN PARTICULAR AS ANTIDEPRESSANTS, AND THEIR PREPARATION PROCESS
JPS5545619A (en) Preventive for dental caries